These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3442407)

  • 1. Effects of DMDP, a tiapamil analogue, on adriamycin efflux in adriamycin-resistant and -sensitive P388 cells.
    Radel S; Mayhew E; Rustum YM
    Anticancer Res; 1987; 7(6):1105-8. PubMed ID: 3442407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
    Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo.
    Radel S; Bankusli I; Mayhew E; Rustum YM
    Cancer Chemother Pharmacol; 1988; 21(1):25-30. PubMed ID: 3342462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.
    Yin MB; Bankusli I; Frank C; Rustum YM
    Anticancer Res; 1990; 10(2A):327-32. PubMed ID: 2346306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the in vivo resistance to adriamycin and modulation by calcium channel blockers in mice.
    Yin MB; Bankusli I; Rustum YM
    Cancer Res; 1989 Sep; 49(17):4729-33. PubMed ID: 2758408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T
    Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
    De Jong G; Gelmon K; Bally M; Goldie J; Mayer L
    Anticancer Res; 1995; 15(3):911-6. PubMed ID: 7645981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S; Samy TS; Krishan A
    Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
    Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
    Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to anthracyclines in P388/dx leukaemia cells.
    Bossa R; Dasdia T; Galatulas I; Zunino F
    Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
    Ramu A; Shan TC; Glaubiger D
    Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
    Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
    Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.